Resveratrol ameliorates lipopolysaccharide-induced epithelial mesenchymal transition and pulmonary fibrosis through suppression of oxidative stress and transforming growth factor-β1 signaling

Clinical Nutrition

Volumn 34, Issue 4, 2015, Pages 752-760

  Zhang, Yun Qian ^a,b   Liu, Yu Jian ^b   Mao, Yan Fei ^a   Dong, Wen Wen ^a   Zhu, Xiao Yan ^b   Jiang, Lai ^a  

^a XINHUA HOSPITAL AFFILIATED TO SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Epithelial mesenchymal transition; Oxidative stress; Pulmonary fibrosis; Resveratrol; TGF 1

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CATALASE; COLLAGEN; COLLAGEN TYPE 1; HYDROXYPROLINE; MALONALDEHYDE; RESVERATROL; SMAD2 PROTEIN; SMAD3 PROTEIN; SMAD4 PROTEIN; SUPEROXIDE DISMUTASE; TRANSFORMING GROWTH FACTOR BETA1; UVOMORULIN; LIPOPOLYSACCHARIDE; STILBENE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFICACY; DRUG MECHANISM; EPITHELIAL MESENCHYMAL TRANSITION; LUNG FIBROSIS; MOUSE; NONHUMAN; OXIDATIVE STRESS; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; ANIMAL; CHEMICALLY INDUCED; DISEASE MODEL; DRUG EFFECTS; GENETICS; INSTITUTE FOR CANCER RESEARCH MOUSE; MALE; METABOLISM; PULMONARY FIBROSIS;

ANIMALS; CATALASE; COLLAGEN TYPE I; DISEASE MODELS, ANIMAL; EPITHELIAL-MESENCHYMAL TRANSITION; LIPOPOLYSACCHARIDES; MALE; MALONDIALDEHYDE; MICE; MICE, INBRED ICR; OXIDATIVE STRESS; PULMONARY FIBROSIS; SIGNAL TRANSDUCTION; STILBENES; SUPEROXIDE DISMUTASE; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84930706436     PISSN: 02615614     EISSN: 15321983     Source Type: Journal    
DOI: 10.1016/j.clnu.2014.08.014     Document Type: Article

References (30)

1. Rubenfeld G.D., Caldwell E., Peabody E., Weaver J., Martin D.P., Neff M., et al. Incidence and outcomes of acute lung injury. NEngl J Med 2005, 353:1685-1693.
2. Burnham E.L., Janssen W.J., Riches D.W., Moss M., Downey G.P. The fibroproliferative response in ARDS: mechanisms and clinical significance. Eur Respir J 2014, 43:276-285.
3. Rocco P.R., Dos Santos C., Pelosi P. Lung parenchyma remodeling in acute respiratory distress syndrome. Minerva Anestesiol 2009, 75:730-740.
4. Papazian L., Doddoli C., Chetaille B., Gernez Y., Thirion X., Roch A., et al. Acontributive result of open-lung biopsy improves survival in acute respiratory distress syndrome patients. Crit Care Med 2007, 35:755-762.
5. Cottin V. Interstitial lung disease. Eur Respir Rev 2013, 22:26-32.
6. Chapman H.A. Epithelial-mesenchymal interactions in pulmonary fibrosis. Annu Rev Physiol 2011, 73:413-435.
7. Jing Y.Y., Han Z.P., Sun K., Zhang S.S., Hou J., Liu Y., et al. Toll-like receptor 4 signaling promotes epithelial-mesenchymal transition in human hepatocellular carcinoma induced by lipopolysaccharide. BMC Med 2012, 10:98.
8. Zhao L., Yang R., Cheng L., Wang M., Jiang Y., Wang S. LPS-induced epithelial-mesenchymal transition of intrahepatic biliary epithelial cells. JSurg Res 2011, 171:819-825.
9. Chen M.C., Chang W.W., Kuan Y.D., Lin S.T., Hsu H.C., Lee C.H. Resveratrol inhibits LPS-induced epithelial-mesenchymal transition in mouse melanoma model. Innate Immun 2012, 18:685-693.
10. Cannito S., Novo E., di Bonzo L.V., Busletta C., Colombatto S., Parola M. Epithelial-mesenchymal transition: from molecular mechanisms, redox regulation to implications in human health and disease. Antioxid Redox Signal 2010, 12:1383-1430.
11. Willis B.C., Borok Z. TGF-beta-induced EMT: mechanisms and implications for fibrotic lung disease. Am J Physiol Lung Cell Mol Physiol 2007, 293:L525-L534.
12. Langen R.C., Korn S.H., Wouters E.F. ROS in the local and systemic pathogenesis of COPD. Free Radic Biol Med 2003, 35:226-235.
13. Khadaroo R.G., Kapus A., Powers K.A., Cybulsky M.I., Marshall J.C., Rotstein O.D. Oxidative stress reprograms lipopolysaccharide signaling via Src kinase-dependent pathway in RAW 264.7 macrophage cell line. JBiol Chem 2003, 278:47834-47841.
14. Liu R.M., Choi J., Wu J.H., Gaston Pravia K.A., Lewis K.M., Brand J.D., et al. Oxidative modification of nuclear mitogen-activated protein kinase phosphatase 1 is involved in transforming growth factor beta1-induced expression of plasminogen activator inhibitor 1 in fibroblasts. JBiol Chem 2010, 285:16239-16247.
15. Chung J.H., Manganiello V., Dyck J.R. Resveratrol as a calorie restriction mimetic: therapeutic implications. Trends Cell Biol 2012, 22:546-554.
16. Sener G., Topaloglu N., Sehirli A.O., Ercan F., Gedik N. Resveratrol alleviates bleomycin-induced lung injury in rats. Pulm Pharmacol Ther 2007, 20:642-649.
17. Zhang H.X., Duan G.L., Wang C.N., Zhang Y.Q., Zhu X.Y., Liu Y.J. Protective effect of resveratrol against endotoxemia-induced lung injury involves the reduction of oxidative/nitrative stress. Pulm Pharmacol Ther 2013, published online Aug 3. 10.1016/j.pupt.2013.07.007.
18. Wei W., Ma B., Li H.Y., Jia Y., Lv K., Wang G., et al. Biphasic effects of selective inhibition of transforming growth factor beta1 activin receptor-like kinase on LPS-induced lung injury. Shock 2010, 33:218-224.
19. Yang T., Mao Y.F., Liu S.Q., Hou J., Cai Z.Y., Hu J.Y., et al. Protective effects of the free radical scavenger edaravone on acute pancreatitis-associated lung injury. Eur J Pharmacol 2010, 630:152-157.
20. Li H., Du S., Yang L., Chen Y., Huang W., Zhang R., et al. Rapid pulmonary fibrosis induced by acute lung injury via a lipopolysaccharide three-hit regimen. Innate Immun 2009, 15:143-154.
21. Massagué J. TGFbeta signalling in context. Nat Rev Mol Cell Biol 2012, 13:616-630.
22. López-Collazo E., Del Fresno C. Pathophysiology of endotoxin tolerance: mechanisms and clinical consequences. Crit Care 2013, 17:242.
23. He Z., Gao Y., Deng Y., Li W., Chen Y., Xing S., et al. Lipopolysaccharide induces lung fibroblast proliferation through toll-like receptor 4 signaling and the phosphoinositide3-kinase-Akt pathway. PLoS One 2012, 7:e35926.
24. Qi S., den Hartog G.J., Bast A. Superoxide radicals increase transforming growth factor-beta1 and collagen release from human lung fibroblasts via cellular influx through chloride channels. Toxicol Appl Pharmacol 2009, 237:111-118.
25. Gorowiec M.R., Borthwick L.A., Parker S.M., Kirby J.A., Saretzki G.C., Fisher A.J. Free radical generation induces epithelial-to-mesenchymal transition in lung epithelium via a TGF-beta1-dependent mechanism. Free Radic Biol Med 2012, 52:1024-1032.
26. van der Vliet A., Cross C.E. Oxidants, nitrosants, and the lung. Am J Med 2000, 109:398-421.
27. Chávez E., Reyes-Gordillo K., Segovia J., Shibayama M., Tsutsumi V., Vergara P., et al. Resveratrol prevents fibrosis, NF-kappaB activation and TGF-beta increases induced by chronic CCl4 treatment in rats. JAppl Toxicol 2008, 28:35-43.
28. Li J., Qu X., Ricardo S.D., Bertram J.F., Nikolic-Paterson D.J. Resveratrol inhibits renal fibrosis in the obstructed kidney: potential role in deacetylation of Smad3. Am J Pathol 2010, 177:1065-1071.
29. Wang H., Zhang H., Tang L., Chen H., Wu C., Zhao M., et al. Resveratrol inhibits TGF-beta1-induced epithelial-to-mesenchymal transition and suppresses lung cancer invasion and metastasis. Toxicology 2013, 303:139-146.
30. Deal E.N., Hollands J.M., Schramm G.E., Micek S.T. Role of corticosteroids in the management of acute respiratory distress syndrome. Clin Ther 2008, 30:787-799.